Literature DB >> 11516874

Forward or inversely planned segmental multileaf collimator IMRT and sequential tomotherapy to treat multiple dominant intraprostatic lesions of prostate cancer to 90 Gy.

P Xia1, B Pickett, E Vigneault, L J Verhey, M Roach.   

Abstract

PURPOSE: To investigate the technical feasibility of using forward or inversely planned segmental multileaf collimator (SMLC) intensity-modulated radiotherapy and sequential tomotherapy (ST) to escalate to a dose of 90 Gy to multiple dominant intraprostatic lesions within the prostate gland while delivering a dose of 75.6 Gy to the remaining prostate. METHODS AND MATERIALS: A selected case with one dominant intraprostatic lesion located at the left base and a second dominant intraprostatic lesion at the right apex of the prostate was planned using three different intensity modulation techniques. Two plans were generated with inverse treatment planning, using either SMLC or ST with a special multivane collimator. The third plan also employed SMLC but was generated using forward planning. All three plans were compared based on dose-volume histograms, isodose distributions, and doses to sensitive normal structures.
RESULTS: All three plans meet and exceed the desired dose constraints, limiting doses to the rectum and bladder to an estimated RTOG Grade 2 complication rate of <10%. The ST plan achieved the best dose conformality, whereas the inverse SMLC plan gave the lowest dose to the rectal wall, and the forward SMLC plan obtained the best dose homogeneity inside the targets.
CONCLUSIONS: Using any of the three intensity-modulated techniques, it is technically feasible to concurrently treat multiple selected high-risk regions within the prostate to 90 Gy and the remaining prostate to 75.6 Gy, while keeping the doses to the rectum and the bladder significantly lower than those associated with a Grade 2 complication rate of 10%.

Entities:  

Mesh:

Year:  2001        PMID: 11516874     DOI: 10.1016/s0360-3016(01)01643-1

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  21 in total

Review 1.  Positron emission tomography in pediatric radiation oncology: integration in the treatment-planning process.

Authors:  Matthew J Krasin; Melissa M Hudson; Sue C Kaste
Journal:  Pediatr Radiol       Date:  2004-01-27

2.  On the impact of functional imaging accuracy on selective boosting IMRT.

Authors:  Y Kim; W A Tomé
Journal:  Phys Med       Date:  2008-01-18       Impact factor: 2.685

3.  Is it beneficial to selectively boost high-risk tumor subvolumes? A comparison of selectively boosting high-risk tumor subvolumes versus homogeneous dose escalation of the entire tumor based on equivalent EUD plans.

Authors:  Yusung Kim; Wolfgang A Tome
Journal:  Acta Oncol       Date:  2008       Impact factor: 4.089

4.  Parameters favorable to intraprostatic radiation dose escalation in men with localized prostate cancer.

Authors:  Nadine Housri; Holly Ning; John Ondos; Peter Choyke; Kevin Camphausen; Deborah Citrin; Barbara Arora; Uma Shankavaram; Aradhana Kaushal
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-10-06       Impact factor: 7.038

5.  Choline PET based dose-painting in prostate cancer--modelling of dose effects.

Authors:  Maximilian Niyazi; Peter Bartenstein; Claus Belka; Ute Ganswindt
Journal:  Radiat Oncol       Date:  2010-03-18       Impact factor: 3.481

Review 6.  Advances in MR spectroscopy of the prostate.

Authors:  John Kurhanewicz; Daniel B Vigneron
Journal:  Magn Reson Imaging Clin N Am       Date:  2008-11       Impact factor: 2.266

Review 7.  New developments in radiation therapy for head and neck cancer: intensity-modulated radiation therapy and hypoxia targeting.

Authors:  Nancy Y Lee; Quynh-Thu Le
Journal:  Semin Oncol       Date:  2008-06       Impact factor: 4.929

8.  Does local recurrence of prostate cancer after radiation therapy occur at the site of primary tumor? Results of a longitudinal MRI and MRSI study.

Authors:  Elnasif Arrayeh; Antonio C Westphalen; John Kurhanewicz; Mack Roach; Adam J Jung; Peter R Carroll; Fergus V Coakley
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-02-11       Impact factor: 7.038

Review 9.  Current role and future perspectives of magnetic resonance spectroscopy in radiation oncology for prostate cancer.

Authors:  Aleksandra Zapotoczna; Giuseppe Sasso; John Simpson; Mack Roach
Journal:  Neoplasia       Date:  2007-06       Impact factor: 5.715

10.  A planning study of focal dose escalations to multiparametric MRI-defined dominant intraprostatic lesions in prostate proton radiation therapy.

Authors:  Tonghe Wang; Jun Zhou; Sibo Tian; Yinan Wang; Pretesh Patel; Ashesh B Jani; Katja M Langen; Walter J Curran; Tian Liu; Xiaofeng Yang
Journal:  Br J Radiol       Date:  2020-01-06       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.